Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Table 1.

Patient characteristics and dose-adjusted concentrations and reciprocal ratios of CBZ and its major metabolites CBZE and CBZD.

CBZE: carbamazepine-10,11-epoxide; CBZD: 10,11-dihydroxy-carbazepine.

More »

Table 1 Expand

Fig 1.

Correlation between CBZ and CBZE plasma concentrations (Pearson’s correlation coefficient R).

More »

Fig 1 Expand

Fig 2.

Graphical representation of adjusted odds ratio and 95% confidence intervals according to the SCN1A genes polymorphism; genotype and allele frequencies in epilepsy patients vs. healthy control subjects.

More »

Fig 2 Expand

Fig 3.

Graphical representations (box-plot) of the sodium channels (SCN1A IVS5-91 G>A) SNPs genotypes associations with (A) CBZ daily dosage (mg/day), (B) CBZ maintenance dose (mg/kg per day), (C) CDRCBZ and (D) CBZD:CBZ.

Statistical significance for difference of means is shown (P values, one way ANOVA analysis followed by Student’s T-test).

More »

Fig 3 Expand

Table 2.

CBZ daily dose, maintenance dose, concentration/dose adjusted ratios of CBZ, CBZE, CBZD and their concentration ratios stratified by individual SNPs genotypes.

Data are mean ± standard deviations.

More »

Table 2 Expand

Fig 4.

Graphical representations (box-plot) of the EPHX1 c.416A>G genotypes associations with (A) CBZD:CBZ, (B) CBZD:CBZE and (C) CDRCBZD,.

CBZ: Carbamazepine; CBZD: Carbamazepine-10,11-trans dihydrodiol; CBZE: Carbamazepine-10,11-epoxide; CDR: Concentration/dose ratio. Data are mean ± standard deviations. Statistical significance for difference of means is shown (P values, one way ANOVA analysis followed by Student’s T-test).

More »

Fig 4 Expand

Fig 5.

Graphical representations (box-plot) of the EPHX1 c.377T>C genotypes with CDRCBZ CBZ: Carbamazepine; CDR: Concentration/dose ratio.

Data are mean ± standard deviations. Statistical significance for difference of means is shown (P values, one way ANOVA analysis followed by Student’s T-test).

More »

Fig 5 Expand

Fig 6.

Graphical representations (box-plot) of the assessment of CBZ resistance due to patient response to therapy (A) CBZ daily dosage (mg/day), (B) CBZ maintenance dose (mg/kg per day) and (C) CBZ plasma concentration (μg/mL).

Data are mean ± standard deviations. Statistical significance for difference of means is shown (P values, Student’s T-test).

More »

Fig 6 Expand

Table 3.

Distribution of SCN1A, ABCB1, EPHX1 genes polymorphism in drug-resistant and drug-responsive epileptic patients.

More »

Table 3 Expand